Benign Prostatic Hyperplasia (Enlarged Prostate) News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Benign prostatic hyperplasia surgical scoring (BPHSS): an novel scoring system for the perioperative outcomes of ... - UroToday



Benign prostatic hyperplasia surgical scoring (BPHSS): an novel scoring system for the perioperative outcomes of ... 
UroToday
To develop a standardized scoring system, the BPH surgical scoring (BPHSS) system, to quantify the ability to predict the perioperative outcomes resulting from an enlarged prostate. There are two parts included in this study: the retrospective ...

 


Pathophysiology of clinical benign prostatic hyperplasia. - UroToday



Pathophysiology of clinical benign prostatic hyperplasia. 
UroToday
In clinical benign prostatic hyperplasis (BPH), the abnormal anatomy is prostate adenoma/adenomata, resulting in a varying degree of benign prostatic obstruction (BPO) that may cause harm to the bladder or kidneys. Thus clinical BPH can be defined as ...

 


The 3D Urology And Prostate Clinics Of Dr Song Offers Advanced And Result-oriented Treatments For Prostate Cancer - Digital Journal



The 3D Urology And Prostate Clinics Of Dr Song Offers Advanced And Result-oriented Treatments For Prostate Cancer 
Digital Journal
Additionally, the prostate is also responsible for pushing the semen through the seminiferous tubules via muscular action to the tip of the penis for ejaculation during intercourse. However, as an individual grows older, this gland becomes enlarged ...

and more » 


Prostate cancer: 'Whole' Mediterranean diet could reduce your risk - Medical News Today



Medical News Today
 
Prostate cancer: 'Whole' Mediterranean diet could reduce your risk 
Medical News Today
A study of three diets found that only a high adherence to the whole Mediterranean dietary pattern is linked to lower risk of aggressive prostate cancer.

and more » 


NxThera Announces Three-Year Outcomes Data Demonstrating ... - PR Newswire (press release)



NxThera Announces Three-Year Outcomes Data Demonstrating ... 
PR Newswire (press release)
MAPLE GROVE, Minn., Jan. 3, 2018 /PRNewswire/ -- NxThera, Inc., a medical device company pioneering the application of its Convective Water Vapor Energy (WAVEŽ) platform technology to treat endourological conditions, announced the three-year outcomes ...

and more » 


Newly Published Economic Analysis Finds NxThera's Minimally ... - Markets Insider



Newly Published Economic Analysis Finds NxThera's Minimally ... 
Markets Insider
MAPLE GROVE, Minn., Jan. 18, 2018 /PRNewswire/ -- NxThera, Inc., a medical device company pioneering the application of its Convective Water Vapor Energy (WAVEŽ) technology to treat endourological conditions, today announced publication of a recent ...

and more » 


Trump Health Exam: President Still Taking Hair Loss Drug Even After Research Revealed Link to Erectile Dysfunction ... - Newsweek



Newsweek
 
Trump Health Exam: President Still Taking Hair Loss Drug Even After Research Revealed Link to Erectile Dysfunction ... 
Newsweek
It's prescribed for the treatment of androgenetic alopecia and benign prostatic hyperplasia, the medical names for what are more commonly referred to as male pattern baldness and an enlarged prostate, according to the Mayo Clinic. The drug is a hormone ...

and more » 


Sophiris Bio (SPHS) PT Set at $6.00 by HC Wainwright - The Lincolnian Online



Nasdaq Fortune
 
Sophiris Bio (SPHS) PT Set at $6.00 by HC Wainwright 
The Lincolnian Online
Sophiris Bio logo Sophiris Bio (NASDAQ:SPHS) has been assigned a $6.00 price target by HC Wainwright in a report issued on Wednesday. The firm presently has a ?buy? rating on the biopharmaceutical company's stock. HC Wainwright's target price would ...
Sophiris Bio (SPHS) Given a $6.00 Price Target at HC Wainwright ... The Ledger Gazette
Sophiris Bio (NASDAQ:SPHS) vs. Parnell Pharmaceuticals Holdings (PARN) Critical Analysis BangaloreWeekly
Somewhat Positive Media Coverage Somewhat Unlikely to Affect ... BBNS
Week Herald  -American Consumer News, LLC 
all 14 news articles » 


Prostate enlargement: One in three men over 50 at risk ? BPH symptoms explained - Express.co.uk



Express.co.uk
 
Prostate enlargement: One in three men over 50 at risk ? BPH symptoms explained 
Express.co.uk
If you have these symptoms, Dr Renee recommended seeing a doctor since prostate enlargement could lead to worrying complications. ?You could develop acute urinary retention, where urine can't come out at all,? she warned. ?This is a medical emergency ...

 


FDA Grants De Novo Request for PROCEPT BioRobotics ... - Business Wire (press release)



FDA Grants De Novo Request for PROCEPT BioRobotics ... 
Business Wire (press release)
REDWOOD SHORES, Calif.--(BUSINESS WIRE)--PROCEPT BioRobotics, a Silicon Valley surgical robotics company developing novel and disruptive technologies to treat prostate disease, announced that the U.S. Food and Drug Administration (FDA) has granted a De ...

and more »